Emerald Provides Corporate Update and Lays out 2017 Growth Initiatives VICTORIA, Feb. 22, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (OTC: TBQBF) ((“Emerald” or the “Company”) provides...
After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well...
Emerald Announces Closing of $13.8 Million Bought Deal VICTORIA, Feb. 10, 2017 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) is pleased to announce the closing...
Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products OTTAWA, Feb. 7, 2017 /CNW/ – Recently, two licensed producers of cannabis...
Canadian licensed producer Emerald Health (TSXV: EMH) (OTC: TBQBF) announced a bought deal to raise $10mm by selling 7.408mm Units at $1.35 consisting of common shares and a warrant...
Blogger Marc Davis profiled Emerald Health (TSXV: EMH) (OTC: TBQBF) recently, discussing the strategy of its Executive Chairman, Dr. Avtar Dhillon, who is building a business focused on medical...
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
Emerald Health Launches Cannabis Oil VICTORIA, Sept. 22, 2016 /CNW/ – Emerald Health Therapeutics Inc. (TSXV: EMH) (“Therapeutics”) is pleased to announced that its wholly owned subsidiary, Emerald Health...
When Justin Trudeau and the Liberal Party won a majority of seats in the Canadian Parliament elections in October last year, it set off a quick pop in the...
Despite a rapidly growing underlying industry, investors in the publicly-traded cannabis stocks have been dodging landmines for several years now, with few companies producing solid returns so far and...
Alan Brochstein published an article on the publicly-traded Canadian cannabis stocks, including Aphria, Aurora Cannabis, Canopy Growth, Emerald Health, Mettrum, OrganiGram, PharmaCan Capital and Supreme Pharma. The article, which is...
